2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide

C18H17N5O — CID 56915831

IUPAC2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide
SMILESCC(C(=O)NCc1cnn2ccccc12)n1cnc2ccccc21
InChIInChI=1S/C18H17N5O/c1-13(22-12-20-15-6-2-3-8-17(15)22)18(24)19-10-14-11-21-23-9-5-4-7-16(14)23/h2-9,11-13H,10H2,1H3,(H,19,24)
InChIKeyZIYVYVRBYXLMOP-UHFFFAOYSA-N
MW319.37 g/mol
LogP2.56
Rot. Bonds4

About 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide

2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide (PubChem CID 56915831) has the molecular formula C18H17N5O and a molecular weight of 319.37 g/mol. Its IUPAC name is 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide.

Molecular Properties

Compound Name2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide
PubChem CID56915831
Molecular FormulaC18H17N5O
Molecular Weight319.37 g/mol
Exact Mass319.14
IUPAC Name2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide
SMILESCC(C(=O)NCc1cnn2ccccc12)n1cnc2ccccc21
InChIInChI=1S/C18H17N5O/c1-13(22-12-20-15-6-2-3-8-17(15)22)18(24)19-10-14-11-21-23-9-5-4-7-16(14)23/h2-9,11-13H,10H2,1H3,(H,19,24)
InChIKeyZIYVYVRBYXLMOP-UHFFFAOYSA-N
XLogP2.56
TPSA64.22 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500319.37
LogP ≤ 52.56
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-chloro-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide
CID 90538425
(2R)-2-(2-oxopyrrolidin-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide
CID 95717558
(2R)-2-(benzimidazol-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]propanamide
CID 95148434
(2S)-2-(benzimidazol-1-yl)-N-[(2,4-dioxo-1H-pyrimidin-5-yl)methyl]propanamide
CID 99974414
(2S)-2-(benzimidazol-1-yl)-N-prop-2-enylpropanamide
CID 39041110
3-methyl-3-(pyrazolo[1,5-a]pyridin-3-ylmethylamino)butan-2-ol
CID 113342065
N-[2-[2-(benzimidazol-1-yl)propanoylamino]ethyl]benzamide
CID 42959454
(2S)-2-(benzimidazol-1-yl)-N-[(2-phenyl-1,3-oxazol-4-yl)methyl]propanamide
CID 129397081
2-(benzimidazol-1-yl)-N-[[6-(1,2,4-triazol-1-yl)-3-pyridinyl]methyl]propanamide
CID 47057339
2-(benzimidazol-1-yl)-N-(2-hydroxypentyl)propanamide
CID 115700986
2-(benzimidazol-1-yl)-N-(2-pyridin-4-ylethyl)propanamide
CID 75679386
2-(benzimidazol-1-yl)-N-[(1,3-dimethyl-2-oxobenzimidazol-5-yl)methyl]propanamide
CID 90650920

Frequently Asked Questions

What is the IUPAC name of 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide?
The IUPAC name of 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide (CID 56915831) is 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide.
What is the SMILES notation for 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide?
The canonical SMILES for 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide is CC(C(=O)NCc1cnn2ccccc12)n1cnc2ccccc21.
What is the InChIKey of 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide?
The InChIKey is ZIYVYVRBYXLMOP-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H17N5O/c1-13(22-12-20-15-6-2-3-8-17(15)22)18(24)19-10-14-11-21-23-9-5-4-7-16(14)23/h2-9,11-13H,10H2,1H3,(H,19,24).
What are the key properties of 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide?
2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide has a molecular weight of 319.37 g/mol, XLogP of 2.56, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(benzimidazol-1-yl)-N-(pyrazolo[1,5-a]pyridin-3-ylmethyl)propanamide is sourced from PubChem (CID 56915831), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).